Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Gene therapy with p53 tumor suppressors].

Literature DB >> 12835851

[Gene therapy with p53 tumor suppressors].

A Dietz¹, D Esser, M Helbig, F X Bosch.

Abstract

Entities: Disease Gene

Mesh：

Year: 2003 PMID： 12835851 DOI： 10.1007/s00106-003-0850-x

Source DB: PubMed Journal: HNO ISSN： 0017-6192 Impact factor: 1.284

Keyword Cloud
References

× No keyword cloud information.

9 in total

Review 1. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].

Authors: F X Bosch; N Homann; C Conradt; A Dietz; R Erber
Journal: HNO Date: 1999-09 Impact factor: 1.284

2. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.

Authors: J Nemunaitis; S G Swisher; T Timmons; D Connors; M Mack; L Doerksen; D Weill; J Wait; D D Lawrence; B L Kemp; F Fossella; B S Glisson; W K Hong; F R Khuri; J M Kurie; J J Lee; J S Lee; D M Nguyen; J C Nesbitt; R Perez-Soler; K M Pisters; J B Putnam; W R Richli; D M Shin; G L Walsh; J Merritt; J Roth
Journal: J Clin Oncol Date: 2000-02 Impact factor: 44.544

3. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer.

Authors: R Erber; C Conradt; N Homann; C Enders; M Finckh; A Dietz; H Weidauer; F X Bosch
Journal: Oncogene Date: 1998-04-02 Impact factor: 9.867

4. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.

Authors: N Homann; M Nees; C Conradt; A Dietz; H Weidauer; H Maier; F X Bosch
Journal: Clin Cancer Res Date: 2001-02 Impact factor: 12.531

9. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region.

Authors: Ulrich Hauser; Vera Balz; Thomas E Carey; Reidar Grénman; Anke Van Lierop; Kathrin Scheckenbach; Henning Bier
Journal: Head Neck Date: 2002-09 Impact factor: 3.147

9 in total

[Gene therapy with p53 tumor suppressors].

Review 1. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].

2. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.

3. TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer.

4. Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.

5. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.

6. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

Review 7. Anti-oncogene and tumor suppressor gene therapy--examples from a lung cancer animal model.

8. Safety evaluation of Ad5CMV-p53 in vitro and in vivo.

9. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region.